CA Patent

CA3204340A1 — Conjugated oligonucleotide compounds, methods of making and uses thereof

Assigned to E Therapeutics PLC · Expires 2022-08-04 · 4y expired

What this patent protects

The present invention relates to novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases an…

USPTO Abstract

The present invention relates to novel conjugated oligonucleotide compounds, which are suitable for therapeutic use. Additionally, the present invention provides methods of making these compounds, as well as methods of using such compounds for the treatment of various diseases and conditions.

Drugs covered by this patent

Patent Metadata

Patent number
CA3204340A1
Jurisdiction
CA
Classification
—
Expires
2022-08-04
Drug substance claim
No
Drug product claim
No
Assignee
E Therapeutics PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.